CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- 4 Open-market buy 10% owner bought 400,000 shares at $3.50 ($1,400,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 24,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 17,000 shares (option exercise)
- 4 Grant or award Director acquired 15,917 shares (grant or award)
- 4 Grant or award Director acquired 10,861 shares (grant or award)
- 4 Grant or award Director acquired 9,925 shares (grant or award)
- 4 Grant or award Director acquired 10,393 shares (grant or award)
- 4 Grant or award Director acquired 5,290 shares (grant or award)
- 4 Open-market buy 10% owner bought 1,200,000 shares at $2.50 ($3,000,000)
- 4 Open-market buy 10% owner bought 1,200,000 shares at $2.50 ($3,000,000)
Page 2 of 9 · 176 filings